PATH EX
PATH EX, Inc. (www.pathex.co) is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections.
1
Funding Rounds
$5.0m
Money raised
Overview
PATH EX, Inc. (www.pathex.co) is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections.
- Website:
- Business model: B2B
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company PATH EX has raised a total of $5m in funding over 1 rounds.
Key Insights:
- PATH EX May 2025 Venture - Series Unknown Funding Round: $5m
PATH EX May 2025 Venture - Series Unknown Funding Round
$5m
Industries
PATH EX is active in the following industries: